RxDoctor Payments Data

Andrew Ross, DO

Family Medicine · Solon, OHNPI 1427558873

Payments from drug & device makers

$993in general payments, 2019–2025

Across 55 payments — averaging $18.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$170
  • Novo Nordisk$163
  • Lilly USA, LLC$119
  • Esperion Therapeutics, Inc.$105
  • AstraZeneca$89
  • GSK$76
  • plus $270 from 10 others

What the payments were for

  • Food & beverage$993100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$993 in reported general payments places this provider in the 60th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$91,379
Medicare patients
468
Services billed
1,152

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide80$88,671
JardianceEmpagliflozin53$72,400
EliquisApixaban37$43,765
RybelsusSemaglutide22$39,067
Budesonide ErBudesonide15$30,821
FarxigaDapagliflozin Propanediol17$26,257
EntrestoSacubitril/Valsartan13$22,609
XareltoRivaroxaban14$22,360
JanuviaSitagliptin Phosphate12$20,000
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$19,955
MounjaroTirzepatide11$15,583
Nurtec OdtRimegepant Sulfate11$15,227
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$8,974
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr16$7,601
Lantus SolostarInsulin Glargine,hum.Rec.Anlog17$5,249

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$163$127,737102 claims
PfizerEliquis, Nurtec Odt$13$58,99248 claims
AstraZenecaFarxiga, Breztri Aerosphere$89$35,23131 claims
GSKTrelegy Ellipta, Anoro Ellipta$76$27,55747 claims
NovartisEntresto$15$22,60913 claims
Johnson & JohnsonXarelto$25$22,36014 claims
Lilly USA, LLCMounjaro$119$15,58311 claims
AbbVieSynthroid$170$1,18025 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Solon

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →